Reviva Pharmaceuticals Holdings (Reviva Pharmaceuticals Holdings) Price-to-Tangible-Book : (As of Jun. 08, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Reviva Pharmaceuticals Holdings Price-to-Tangible-Book?

As of today (2024-06-08), Reviva Pharmaceuticals Holdings's share price is $0.23. Reviva Pharmaceuticals Holdings's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $0.00. Hence, Reviva Pharmaceuticals Holdings's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book or its related term are showing as below:

During the past 5 years, Reviva Pharmaceuticals Holdings's highest Price to Tangible Book Ratio was 81.39. The lowest was 1.04. And the median was 6.12.

RVPHW's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Reviva Pharmaceuticals Holdings's share price is $0.23. Reviva Pharmaceuticals Holdings's Book Value per Sharefor the quarter that ended in Mar. 2024 was $0.00. Hence, Reviva Pharmaceuticals Holdings's P/B Ratio of today is .

Reviva Pharmaceuticals Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reviva Pharmaceuticals Holdings Price-to-Tangible-Book Chart

Reviva Pharmaceuticals Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Reviva Pharmaceuticals Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book falls into.

Reviva Pharmaceuticals Holdings Price-to-Tangible-Book Calculation

Reviva Pharmaceuticals Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.23	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Reviva Pharmaceuticals Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Reviva Pharmaceuticals Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Reviva Pharmaceuticals Holdings (Reviva Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reviva Pharmaceuticals Holdings Inc (NAS:RVPHW) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RVPH:USA

Address

19925 Stevens Creek Boulevard, Suite 100, Cupertino, CA, USA, 95014

Website

https://www.revivapharma.com

Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, 1) Brilaroxazine (RP5063) which is in clinical development and is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and 2) RP1208.